2025/07/17 by Mironova, YA, Giger, RJ
#Amnesia #Animals #Astrocytes #Brain #Brain Injuries #Cell Surface #Chondroitin Sulfate Proteoglycans #Cytoskeleton #Dendrites #Dominance #GPI-Linked Proteins #Glycosaminoglycans #Humans #Mental Disorders #Mice #Models #Myelin Proteins #Nerve Regeneration #Nerve Tissue Proteins #Neurological #Neuronal Plasticity #Nogo Proteins #Nogo Receptor 1 #Ocular #Receptors #Signal Transduction #Spinal Cord Injuries #Synapses
paper · doi:10.7302/26598
Growth inhibitory molecules in the adult mammalian central nervous system (CNS) have been implicated in the blocking of axonal sprouting and regeneration following injury. Prominent CNS regeneration inhibitors include Nogo-A, oligodendrocyte myelin glycoprotein (OMgp), and chondroitin sulfate proteoglycans (CSPGs), and a key question concerns their physiological role in the naïve CNS. Emerging evidence suggests novel functions in dendrites and at synapses of glutamatergic neurons. CNS regeneration inhibitors target the neuronal actin cytoskeleton to regulate dendritic spine maturation, long-term synapse stability, and Hebbian forms of synaptic plasticity. This is accomplished in part by antagonizing plasticity-promoting signaling pathways activated by neurotrophic factors. Altered function of CNS regeneration inhibitors is associated with mental illness and loss of long-lasting memory, suggesting unexpected and novel physiological roles for these molecules in brain health. © 2013 Elsevier Ltd.